BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Derik De Bruin does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 MYGNMyriad Genetics Inc | Sell | $11.00 | Mar 2025 | +56.9% | Hit |
| MYGNMyriad Genetics Inc | Sell | $13.00 | Dec 2024 | +64.5% | Hit |
 STVNStevanato Group SpA | Buy | $26.00 | Dec 2024 | −22.5% | Hit |
 WSTWest Pharmaceutical Services Inc | Buy | $355.00 | Dec 2024 | −31.5% | Miss |
 PAHCPhibro Animal Health Corporation | Sell | $15.00 | Aug 2024 | −99.4% | Miss |
 SEERSeer Inc | Sell | $6.50 | Jan 2023 | +61.0% | Hit |
 DNAGinkgo Bioworks Holdings | Sell | $3.00 | May 2022 | +51.2% | Hit |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.